Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6. This indicates a minor update to the page's version metadata rather than any content changes.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows a new revision tag (v3.6.5) replacing the previous v3.6.4, indicating a minor platform update to the page that does not change study content.SummaryDifference0.0%

- Check36 days agoChange DetectedThe site revision was updated from v3.6.3 to v3.6.4, signalling a maintenance/version update to the ClinicalTrials.gov page infrastructure. The update does not modify the study details, eligibility criteria, or other content presented on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. This change does not modify study data, eligibility criteria, or results.SummaryDifference0.0%

- Check65 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a small internal update to the page's version history. This change does not modify the public study content or visible information.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now displays 'No longer looking for participants' under recruitment status, indicating enrollment is closed. Additionally, new help/navigation sections—'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study'—were added, while the 'Intervention/Treatment' heading was updated in formatting and site revision metadata updated to Revision: v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.